Blood Clot Concerns Prompt EU Restrictions For Pfizer's Xeljanz

 
• By Vibha Sharma
  
SideEffects
The EMA Is Re-Examining The Safety Of Xeljanz • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography